Bayesian Capital Management, LP

Position in GILD — Gilead Sciences, Inc.

CIK 1632551 Brooklyn, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,149,694

+$847,680 QoQ

Shares Held

9,100

+319.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.76%

of 13F equity value

Holder Rank

#1,008

of 2,275 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bayesian Capital Management, LP holds $5,153,335 across 7 Drug Manufacturers - General names. GILD ranks #1 (22.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc. This page	9,100	$1,149,694
2	BMY	Bristol Myers Squibb Co	19,200	$1,106,304
3	GSK	GSK plc	18,100	$948,802
4	AMGN	Amgen Inc	2,384	$863,294
5	NVO	Novo Nordisk A S	8,500	$407,490
6	NVS	Novartis AG	2,365	$370,642
7	SNY	Sanofi	7,199	$307,109

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,149,694	9,100	+319.9%	Shares	Sole	2026-08-14
2026-03-31	$302,014	2,167	-88.6%	Shares	Sole	2026-05-15
2025-09-30	$2,112,996	19,036	-62.7%	Shares	Sole	2025-11-14
2025-03-31	$5,725,755	51,100	+136.6%	Shares	Sole	2025-05-15
2024-12-31	$1,995,192	21,600	+33.3%	Shares	Sole	2025-02-14
2024-03-31	$1,186,650	16,200	-73.5%	Shares	Sole	2024-05-15
2023-09-30	$4,578,834	61,100	+115.9%	Shares	Sole	2023-11-14
2023-03-31	$2,348,051	28,300	+201.1%	Shares	Sole	2023-05-15
2022-09-30	$579,886	9,400	-73.4%	Shares	Sole	2022-11-14
2021-09-30	$2,472,690	35,400	-34.6%	Shares	Sole	2021-11-15
2020-12-31	$3,151,866	54,100	+97.4%	Shares	Sole	2021-02-12
2020-09-30	$1,731,406	27,400	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.